Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-01-10T23:23:31.505Z Has data issue: false hasContentIssue false
  • English
  • Français

Social Anxiety Disorder: Psychobiological and Evolutionary Underpinnings

Published online by Cambridge University Press:  07 November 2014

Dan J. Stein  and
Bavanisha Vythilingum
Get access Rights & Permissions [Opens in a new window]

Abstract

Social anxiety disorder (SAD) also know as social phobia is increasingly recognized as a highly prevalent and disabling psychiatric disorder. SAD patients demonstrate cognitive-affective distortions in relation to social situations and abnormal activation patterns in limbic structures during functional imaging. Behavioral inhibition is an endophenotype that may be useful in understanding vulnerability to SAD, and that has specific imaging and genetic correlates. From an evolutionary perspective, it has been speculated that SAD represents a false appeasement alarm. It is notable that SAD responds to selective serotonin reuptake inhibitors and monoamine oxidase inhibitors, but not to most tricyclic antidepressants; this finding is consistent with the importance of serotonin and dopamine in mediating this disorder.

Type
Pearls in Clinical Neuroscience
Information
CNS Spectrums , Volume 12 , Issue 11 , November 2007 , pp. 806 - 809
Copyright
Copyright © Cambridge University Press 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Clark, DM, McManus, F. Information processing in social phobia. Biol Psychiatry. 2002;51:92–100.CrossRefGoogle ScholarPubMed
2.Rapee, RM, Spence, SH. The etiology of social phobia: empirical evidence and an initial model. Clin Psychol Rev. 2004;24:737–767.CrossRefGoogle Scholar
3.Amir, N, Elias, J, Klumpp, H, Przeworski, A. Attentional bias to threat in social phobia: facilitated processing of threat or difficulty disengaging attention from threat? Behav Res Ther. 2003;41:1325–1335.CrossRefGoogle ScholarPubMed
4.Foa, EB, Gilboa-Schechtman, E, Amir, N, Freshman, M. Memory bias in generalized social phobia: remembering negative emotional expressions. J Anxiety Disord. 2000;14:501–519.CrossRefGoogle ScholarPubMed
5.Stopa, L, Clark, DM. Social phobia and interpretation of social events. Behav Res Ther. 2000;38:273–283.CrossRefGoogle ScholarPubMed
6.Rapee, RM, Abbott, MJ. Mental representation of observable attributes in people with social phobia. J Behav Ther Exp Psychiatry. 2006;37:113–126.CrossRefGoogle ScholarPubMed
7.Stein, MB, Goldin, PR, Sareen, J, Zorrilla, LTBrown, GG. Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry. 2002;59:1027–1034.CrossRefGoogle ScholarPubMed
8.Etkin, A, Wager, TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007;164:1476–1488.CrossRefGoogle ScholarPubMed
9.Phan, KL, Fitzgerald, DA, Nathan, PJ, Tancer, ME. Association between amygdala hyperactivity to harsh faces and severity of social anxiety in generalized social phobia. Biol Psychiatry. 2006;59:424–429.CrossRefGoogle ScholarPubMed
10.Van der Linden, G, van Heerden, B, Warwick, J, et al.Functional brain imaging and pharmacotherapy in social phobia: single photon emission computed tomography before and after treatment with the selective serotonin reuptake inhibitor citalopram. Prog Neuropsychopharmacol Biol Psychiatry. 2000;24:419–438.CrossRefGoogle ScholarPubMed
11.Furmark, T, Tillfors, M, Marteinsdottir, I, et al.Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatry. 2002;59:425–433.CrossRefGoogle ScholarPubMed
12.Furmark, T, Appel, L, Michelgård, A, et al.Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biol Psychiatry. 2005;58:132–142.CrossRefGoogle ScholarPubMed
13.Warwick, JM, Carey, P, Van der Linden, G, et al.A comparison of the effects of citalopram and moclobemide on resting brain perfusion in social anxiety disorder. Metab Brain Dis. 2006;21(2–3):241–252.CrossRefGoogle ScholarPubMed
14.Lanzenberger, RR, Mitterhauser, M, Spindelegger, C, et al.Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry. 2007;61:1081–1089.CrossRefGoogle ScholarPubMed
15.Furmark, T, Tillfors, M, Garpenstrand, H, et al.Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci Lett. 2004;362:189–192.CrossRefGoogle ScholarPubMed
16.Stein, MB, Seedat, S, Gelernter, J. Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder. Psychopharmacology (Berl). 2006;187:68–72.CrossRefGoogle ScholarPubMed
17.Schneier, FR, Liebowitz, MR, Abi-Dargham, A, Zea-Ponce, Y, Lin, SH, Laruelle, M. Low dopamine D(2) receptor binding potential in social phobia. Am J Psychiatry. 2000;157:457–459.CrossRefGoogle ScholarPubMed
18.Tiihonen, J, Kuikka, J, Bergström, K, Lepola, U, Koponen, H, Leinonen, E. Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry. 1997;154:239–242.Google ScholarPubMed
19.Stein, DJ, Westenberg, HG, Liebowitz, MR. Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry. J Clin Psychiatry. 2002;63(suppl 6):12–19.Google ScholarPubMed
20.Sareen, J, Campbell, DW, Leslie, WD, et al.Striatal function in generalized social phobia: a functional magnetic resonance imaging study. Biol Psychiatry. 2007;61:396–404.CrossRefGoogle ScholarPubMed
21.Phan, KL, Fitzgerald, DA, Cortese, BM, Seraji-Bozorgzad, N, Tancer, ME, Moore, GJ. Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla. Neuroreport. 2005;16:183–186.CrossRefGoogle Scholar
22.Kirsch, REsslinger, C, Chen, Q, et al.Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci. 2005;25:11489–11493.CrossRefGoogle ScholarPubMed
23.Prather, MD, Lavenex, P, Mauldin-Jourdain, ML, et al.Increased social fear and decreased fear of objects in monkeys with neonatal amygdala lesions. Neuroscience. 2001;106:653–658.CrossRefGoogle ScholarPubMed
24.Eisenberger, NI, Lieberman, MD, Williams, KD. Does rejection hurt? An FMRI study of social exclusion. Science. 2003;302:290–292.CrossRefGoogle ScholarPubMed
25.Stein, MB. Neurobiological perspectives on social phobia: from affiliation to zoology. Biol Psychiatry. 1998;44:1277–1285.CrossRefGoogle ScholarPubMed
26.Van Ameringen, M, Mancini, C, Farvolden, ROakman, J. The neurobiology of social phobia: from pharmacotherapy to brain imaging. Curr Psychiatry Rep. 2000;2:358–366.CrossRefGoogle ScholarPubMed
27.Stein, MB, Gelernter, J, Smoller, JW. Genetic aspects of social anxiety and related traits. In: Bandelow, B, Stein, DJ, eds. Social Anxiety Disorder: More than Shyness. New York, NY: Marcel Dekker, Inc.; 2004:197–214.Google Scholar
28.Arbelle, S, Benjamin, J, Golin, M, Kremer, I, Belmaker, RH, Ebstein, RP. Relation of shyness in grade school children to the genotype for the long form of the serotonin transporter promoter region polymorphism. Am J Psychiatry. 2003;160:671–676.CrossRefGoogle Scholar
29.Battaglia, M, Ogliari, A, Zanoni, A, et al.Influence of the serotonin transporter promoter gene and shyness on children's cerebral responses to facial expressions. Arch Gen Psychiatry. 2005;62:85–94.CrossRefGoogle ScholarPubMed
30.Smoller, JW, Rosenbaum, JFBiederman, J, et al.Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. Biol Psychiatry. 2003;54:1376–1381.CrossRefGoogle ScholarPubMed
31.Stein, MB, Schork, NJ, Gelernter, J. Gene-by-environment (serotonin transporter and childhood maltreatment) interaction for anxiety sensitivity, an intermediate phenotype for anxiety disorders. Neuropsychopharmacology. 2007 Apr 25; [Epub ahead of print].Google Scholar
32.Rosenbaum, JF, Biederman, J, Bolduc-Murphy, EA, et al.Behavioral inhibition in childhood: a risk factor for anxiety disorders. Harv Rev Psychiatry. 1993;1:2–16.CrossRefGoogle ScholarPubMed
33.Schwartz, CE, Wright, CI, Shin, LM, Kagan, J, Rauch, SL. Inhibited and uninhibited infants ‘grown up’: adult amygdalar response to novelty. Science. 2003;300:1952–1953.CrossRefGoogle ScholarPubMed
34.Guyer, AE, Nelson, EE, Perez-Edgar, K, et al.Striatal functional alteration in adolescents characterized by early childhood behavioral inhibition. J Neurosci. 2006;26:6399–6405.CrossRefGoogle ScholarPubMed
35.Fox, NA, Nichols, KE, Henderson, HA, et al.Evidence for a gene-environment interaction in predicting behavioral inhibition in middle childhood. Psychol Sci. 2005;16:921–926.CrossRefGoogle ScholarPubMed
36.Stein, DJ, Bouwer, C. Blushing and social phobia: a neuroethological speculation. Med Hypotheses. 1997;49:101–108.CrossRefGoogle ScholarPubMed
37.Darwin, C. The Expression of Emotion in Man and Animals. London, UK: John Murray; 1872.CrossRefGoogle Scholar
38.Leary, MR, Britt, TW, Cutlip, WD 2nd, Templeton, JL. Social blushing. Psychol Bull. 1992;112:446–460.CrossRefGoogle ScholarPubMed
39.Muller, JE, Koen, L, Stein, DJ. The spectrum of social anxiety disorders. In: Bandelow, B, Stein, DJ, eds. Social Anxiety Disorder. New York, NY: Marcel Dekker; 2004:19–34Google Scholar
40.Schneier, FR, Blanco, C, Antia, SX, Liebowitz, MR. The social anxiety spectrum. Psychiatr Clin North Am. 2002;25:757–774.CrossRefGoogle ScholarPubMed
41.Mennin, DS, Fresco, DM, Heimberg, RG, Schneier, FR, Davies, SO, Liebowitz, MR. Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale. J Anxiety Disord. 2002;16:661–673.CrossRefGoogle ScholarPubMed
42.Connor, KM, Davidson, JR, Churchill, LE, Sherwood, A, Foa, E, Weisler, RH. Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale. Br J Psychiatry. 2000;176:379–386.CrossRefGoogle ScholarPubMed
43.Connor, KM, Kobak, KA, Churchill, LE, Katzelnick, D, Davidson, JR. Mini-SPIN: a brief screening assessment for generalized social anxiety disorder. Depress Anxiety. 2001;14:137–140.CrossRefGoogle ScholarPubMed
44.Fehm, L, Pelissolo, A, Furmark, T, Wittchen, HU. Size and burden of social phobia in Europe. Eur Neuropsychopharmacol. 2005;15:453–462.CrossRefGoogle ScholarPubMed
45.Heimberg, RG, Stein, MB, Hiripi, E, Kessler, RC. Trends in the prevalence of social phobia in the United States: a synthetic cohort analysis of changes over four decades. Eur Psychiatry. 2000;15:29–37.CrossRefGoogle ScholarPubMed
46.Stein, DJ, Ipser, JC, Balkom, AJ. Pharmacotherapy for social phobia. Cochrane Database Syst Rev. 2004;(4):CD001206.CrossRefGoogle Scholar
47.Blanco, C, Schneier, FR, Schmidt, A, et al.Pharmacological treatment of social anxiety disorder: a meta-analysis. Depress Anxiety. 2003;18:29–40.CrossRefGoogle ScholarPubMed
48.Baldwin, DS, Anderson, IM, Nutt, DJ, et al.Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2005;19:567–596.CrossRefGoogle ScholarPubMed
49.Bandelow, B, Zohar, J, Hollander, E, et al.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. World J Biol Psychiatry. 2002;3:171–199.CrossRefGoogle ScholarPubMed
50.Swinson, RP, Antony, MM, Bleau, PB, et al.Clinical practice guidelines: management of anxiety disorders. Can J Psychiatry. 2006;51(suppl 2):1S–92S.Google Scholar
51.Fedoroff, IC, Taylor, S. Psychological and pharmacological treatments of social phobia: a meta-analysis. J Clin Psychopharmacol. 2001;21:311–324.CrossRefGoogle ScholarPubMed
52.Chavira, DA, Stein, MB. Childhood social anxiety disorder: from understanding to treatment. Child Adolesc Psychiatr Clin N Am. 2005;14:797–818.CrossRefGoogle ScholarPubMed
53.Rapee, RM, Kennedy, S, Ingram, M, Edwards, S, Sweeney, L. Prevention and Early Intervention of Anxiety Disorders in Inhibited Preschool Children. J Consult Clin Psychol. 2005;73:488–497.CrossRefGoogle ScholarPubMed
54.Wakefield, JC, Horwitz, AV, Schmitz, MF. Are we overpathologizing the socially anxious? Social phobia from a harmful dysfunction perspective. Can J Psychiatry. 2005;50:317–319.CrossRefGoogle ScholarPubMed
55.Moynihan, R, Smith, R. Too much medicine? BMJ. 2002;324:859–860.CrossRefGoogle ScholarPubMed
56.Davidson, JR, Hughes, DL, George, LK, Blazer, DG. The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. Psychological Med. 1993;23:709–718.CrossRefGoogle ScholarPubMed
57.Veit, R, Flor, H, Erb, M, et al.Brain circuits involved in emotional learning in antisocial behavior and social phobia in humans. Neurosci Lett. 2002;328:233–236.CrossRefGoogle ScholarPubMed
58.Meyer-Lindenberg, A, Hariri, AR, Munoz, KE, et al.Neural correlates of genetically abnormal social cognition in Williams syndrome. Nat Neurosci. 2005;8:991–993.CrossRefGoogle ScholarPubMed